Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing
Funding Agency: Bill and Melinda Gates Foundation
Deadline: January 31, 2025
Country: All Countries
Budget: USD 750,000
An active membership is required for this action, please click on the button below to view the available plans.